Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study

NCT07574320 is registered in ClinicalTrials.gov with Md. Aminul Islam as lead sponsor.

NCT NCT07574320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07574320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
Lead sponsor
Md. Aminul Islam
Phase
Phase 4
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
February 1, 2027
Enrollment
76 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ibs-d (diarrhea-predominant)